Exploring the Relationship Between Stimulant Use and Serious Mental Illness
Resource Availability
This course material was originally created by SMI Adviser, now rebranded as SMI CalAdviser. The content in this course material is still current and relevant, yet, please be aware that some external resources and links may no longer be active or available. 
Overview

Description 

Individuals with SMI often have co-occurring substance use disorders, including co-occurring stimulant use disorder. This can create confusion when people present for care, as their psychotic symptoms may be related to their recent substance use, or their underlying mental illness, or a combination of both. Very often treatment for co-occurring conditions is not as easily accessible, and practitioners need to have a better understanding of the impacts of stimulant use on individuals with mental illness and how best to treat these issues simultaneously. Furthermore, when an individual is using one substance, they may also be using other substances, which can also make treatment and diagnosis challenging. People with SMI and co-occurring substance use disorders can present with other confounding issues including aggression or behavior associated with criminal conduct. They may be seen in forensic, carceral and emergency department settings as their care is often disrupted across multiple systems. This webinar will provide information about serious mental illness and co-occurring stimulant use disorder and its impact on clinical presentations and ways to address these issues. 

Format 

Recorded webinar, non-interactive, self-paced distance learning activity with post-test.  

This presentation was recorded on December 15, 2023. 

Learning Objectives 

Describe stimulants and how they impact function, along with other co-occurring substance use. 

Describe how stimulant use disorder can impact serious mental illness and vice versa. 

Discuss approaches to assessment and treatment of people with SMI and stimulant use disorder.  

Outline 

  • SMI and Stimulant Use Disorder 
  • Interrelationship and Treatment 
  • Addressing Complexities 
  • Question and Answer 

Target Audience 

Psychiatrist, Physician (Non-Psychiatric), Physician Assistant, Nurse, Nurse Practitioner, Pharmacist, Psychologist, Counselor/Therapist, Social Worker, Peer Specialist 

Instructional Level 

 Intermediate 

Estimate Time to Complete 

Estimated Duration: 1.0 hour 
Program Start Date: July 30, 2025
Program End Date: July 30, 2028

Ongoing Interdisciplinary Discussion Board 

After completing the course, engage with colleagues in the mental health field through SMI Adviser's Webinar Roundtable Topics discussion board. This is an easy way to network and share ideas with other clinicians who participate in this webinar. Access through the discussion tab.  

How to Earn Credit 

After completing the evaluation, participants will have the opportunity to claim their hours of participation and download the appropriate certificate. Physicians may obtain an official CME certificate, other healthcare professionals may receive a CE certificate (as applicable), and all other attendees may generate a certificate of participation. Each certificate will reflect the event date and total hours earned. 

Continuing Education Credit 

In support of improving patient care, American Psychiatric Association (APA) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Physicians   

The APA designates this live event for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

Nurses/Nurse Practitioners   

The American Psychiatric Association (APA) designates this activity for 1.00 Nursing contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.   

Pharmacists  

This curriculum has been approved for 1.00 contact hours by the American Psychiatric Association.  The American Psychiatric Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this program is JA0000145-0000-23-021-H99-P. This learning activity is <<add type of activity>>-based. Your CE credits will be electronically submitted to NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).   

Psychologists   

Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.  

Social Workers    

As a Jointly Accredited Organization, American Psychiatric Association (APA) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. APA maintains responsibility for this course. Social workers completing this course receive up to 1.00 clinical continuing education credits.

***Continuing education requirements vary from state to state. Many state boards grant reciprocity with national accrediting organizations and other state boards. It is the responsibility of each professional to understand the requirements for license renewal or check with the state or national licensing board and/or professional organization to become more familiar with their policies for acceptable continuing education credit. Social workers and Psychologists should contact their regulatory board to determine course approval.

Faculty and Planner Disclosures 

The American Psychiatric Association adheres to the ACCME's Standards for Integrity and Independence in Accredited Medical Education. Any individuals in a position to control the content of a CME activity - including faculty, planners, reviewers, or others - are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.  

Faculty  

  • Debra A. Pinals, MD serves as the director of the Program in Psychiatry, Law, and Ethics and as a clinical professor of psychiatry at the University of Michigan Medical School. She is a clinical adjunct professor at the University of Michigan Law School. She also is the medical director of behavioral health and forensic programs for the Michigan Department of Health and Human Services. During her career she has been a clinical psychiatrist in community mental health, inpatient settings, forensic and correctional facilities, emergency rooms, and court clinics. Dr. Pinals has no financial relationships to disclose. 
  • Charles Scott, MD, is a Professor of Psychiatry and Behavioral Sciences at UC Davis School of Medicine. Dr. Scott has no financial relationships to disclose.  

Program Planners  

  • Teri Brister, PhD, LPC, National Alliance on Mental Illness. Dr. Brister has no relevant financial relationships to disclose. 
  • Amy Cohen, PhD, American Psychiatric Association. Dr. Cohen has no relevant financial relationships to disclose. 
  • John Torous, MD, Beth Israel Deaconess Medical Center. Dr. Torous has no relevant financial relationships to disclose. 
  • Sherin Khan, LCSW, Thresholds. Ms. Khan has no relevant financial relationships to disclose. 
  • Donna Rolin, PhD, APRN, University of Texas at Austin. Dr. Rolin has no relevant financial relationships to disclose. 
  • Megan Ehret, PharmD, BCPP, University of Maryland, Baltimore. Dr. Ehret has no relevant financial relationships to disclose. 

Technical Requirements 

This internet-based CME activity is best experienced using any of the following: 

The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari 

Internet Explorer 11+ 

This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player. 

Optimal System Configuration: 

Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version) 

Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version) 

Internet Connection: 1 Mbps or higher 

Minimum Requirements: 

Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content 

Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content 

For assistance: Contact educme@psych.org for questions about this activity |  

Contact support@smicaladviser.org for technical assistance 

 

 

Summary
Availability:
On-Demand
Expires on Jul 30, 2028
Credit Offered:
1 CME Credit
1 Psychology CE Credit
1 Social Work CE Credit
1 Pharmacy CE Credit
1 COP Credit
Recommended
Powered By